Takeda Pharmaceutical ROI - Return on Investment 2010-2024 | TAK

Takeda Pharmaceutical return on investment for the quarter ending September 30, 2024 was 1.2.

  • Takeda Pharmaceutical average return on investment for 2023 was 2.34, a 40.96% decline from 2022.
  • Takeda Pharmaceutical average return on investment for 2022 was 1.66, a 66.93% increase from 2021.
  • Takeda Pharmaceutical average return on investment for 2021 was 5.02, a 266.42% decline from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

Takeda Pharmaceutical ROI - Return on Investment 2010-2024 | TAK

  • Takeda Pharmaceutical average return on investment for 2023 was 2.34, a 40.96% decline from 2022.
  • Takeda Pharmaceutical average return on investment for 2022 was 1.66, a 66.93% increase from 2021.
  • Takeda Pharmaceutical average return on investment for 2021 was 5.02, a 266.42% decline from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.